论文信息 - Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer - 字舞流文

Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

D. Berry | E. Mardis | C. Fan | C. Perou | E. Winer | K. Hoadley | C. Hudis | J. Parker | Zhiyuan Hu | B. Pitcher | L. Carey | L. Harris | Matthew G. Soloway | T. Hyslop | M. Tanioka | S. Tolaney | P. Spears | I. Krop | C. Dang | Yan Li | Lynn N. Henry